Researchers at the Medical Research Council (MRC) Cancer Cell Unit, Cambridge have gained an important new insight into the role of the breast cancer gene known as BRCA2. It appears to have a key function in cell division which needs to happen accurately for normal cell reproduction and repair, otherwise disease occurs. The findings are published today (29 Friday October 2004) in the journal Science.
Around 30 to 50 per cent of breast cancers that run in families are thought to occur because the BRCA2 gene is not working. People who inherit defective BRCA2 are not only more susceptible to breast cancer, but also have a higher risk of developing cancers of the ovary, pancreas and prostate. The researchers found that where there was a mutation in the BRCA2 gene, cells failed to divide accurately and acquired an incorrect number of chromosomes.*
The final critical step where cells divide is called cytokinesis. This is where a cell separates into two to create replicas of itself known as ‘daughter cells’. It is at this point that a full set of chromosomes is put together for each of the new cells. Any malfunction in this process can result in cells having too few or too many chromosomes or abnormalities, which have implications for disease. Since the discovery of the breast cancer susceptibility genes BRCA1 and BRCA2, researchers have sought to identify exactly why mutations in these genes lead to breast cancer. Understanding the role BRCA2 has in cell division and chromosome separation sheds light on this mechanism and what happens when it goes wrong.
New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia
New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
16.08.2017 | Physics and Astronomy
16.08.2017 | Materials Sciences
16.08.2017 | Interdisciplinary Research